drugset / Trial / NCT02181205

Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

NCT02181205 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators are attempting to determine a less invasive method of treatment for postdural puncture headaches that can occur after regional anesthesia. The investigators will be evaluating the relief of headache with those subjects receiving treatment with a sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with post study treatment versus placebo, and potential side effects of those patients receiving study therapy as well as epidural blood patch.

Timeline

Start
2014-11
Primary completion
2016-12-31
Completion
2016-12-31

Outcome

Outcome not reported

Stopped: “no eligible participant , technical difficulty, feasiblity”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified — —

Indications